Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
583
total citations
- FWCI
- 58.86
- Percentile
- 100%
- References
- 33
Citations per year
Authors
9Topics & keywords
Topics
Keywords
- Tocilizumab
- Medicine
- Giant cell arteritis
- Placebo
- Prednisolone
- Internal medicine
- Surgery
- Clinical trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.